# Detection of Patients With Abnormal Water Distribution Based on Bioelectrical Impedance Analysis (BIA)

> **NCT01481311** · — · COMPLETED · sponsor: **Seca GmbH & Co. Kg.** · enrollment: 62 (actual)

## Conditions studied

- Kidney Diseases

## Interventions

- **DEVICE:** medical Body Composition Analyzer seca 514/515
- **PROCEDURE:** Deuterium and Sodium Bromide dilution methods

## Key facts

- **NCT ID:** NCT01481311
- **Lead sponsor:** Seca GmbH & Co. Kg.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-08
- **Final completion:** 2012-08
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2012-10-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01481311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01481311, "Detection of Patients With Abnormal Water Distribution Based on Bioelectrical Impedance Analysis (BIA)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01481311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*